416 related articles for article (PubMed ID: 26526588)
1. Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses.
Villareal VA; Rodgers MA; Costello DA; Yang PL
Antiviral Res; 2015 Dec; 124():110-21. PubMed ID: 26526588
[TBL] [Abstract][Full Text] [Related]
2. Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens.
Marceau CD; Puschnik AS; Majzoub K; Ooi YS; Brewer SM; Fuchs G; Swaminathan K; Mata MA; Elias JE; Sarnow P; Carette JE
Nature; 2016 Jul; 535(7610):159-63. PubMed ID: 27383987
[TBL] [Abstract][Full Text] [Related]
3. Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.
Blaising J; Pécheur EI
Biochimie; 2013 Jan; 95(1):96-102. PubMed ID: 22884392
[TBL] [Abstract][Full Text] [Related]
4. Direct Activation of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by PF-06409577 Inhibits Flavivirus Infection through Modification of Host Cell Lipid Metabolism.
Jiménez de Oya N; Blázquez AB; Casas J; Saiz JC; Martín-Acebes MA
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712653
[TBL] [Abstract][Full Text] [Related]
5. Dengue Virus Evolution under a Host-Targeted Antiviral.
Plummer E; Buck MD; Sanchez M; Greenbaum JA; Turner J; Grewal R; Klose B; Sampath A; Warfield KL; Peters B; Ramstedt U; Shresta S
J Virol; 2015 May; 89(10):5592-601. PubMed ID: 25762732
[TBL] [Abstract][Full Text] [Related]
6. An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target.
Howe MK; Speer BL; Hughes PF; Loiselle DR; Vasudevan S; Haystead TA
Antiviral Res; 2016 Jun; 130():81-92. PubMed ID: 27058774
[TBL] [Abstract][Full Text] [Related]
7. Discovery of host-targeted covalent inhibitors of dengue virus.
de Wispelaere M; Carocci M; Liang Y; Liu Q; Sun E; Vetter ML; Wang J; Gray NS; Yang PL
Antiviral Res; 2017 Mar; 139():171-179. PubMed ID: 28034743
[TBL] [Abstract][Full Text] [Related]
8. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
Soto-Acosta R; Bautista-Carbajal P; Syed GH; Siddiqui A; Del Angel RM
Antiviral Res; 2014 Sep; 109():132-40. PubMed ID: 25017471
[TBL] [Abstract][Full Text] [Related]
9. The search for nucleoside/nucleotide analog inhibitors of dengue virus.
Chen YL; Yokokawa F; Shi PY
Antiviral Res; 2015 Oct; 122():12-9. PubMed ID: 26241002
[TBL] [Abstract][Full Text] [Related]
10. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
Suzuki T
Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
[TBL] [Abstract][Full Text] [Related]
11. The bioactive lipid 4-hydroxyphenyl retinamide inhibits flavivirus replication.
Carocci M; Hinshaw SM; Rodgers MA; Villareal VA; Burri DJ; Pilankatta R; Maharaj NP; Gack MU; Stavale EJ; Warfield KL; Yang PL
Antimicrob Agents Chemother; 2015 Jan; 59(1):85-95. PubMed ID: 25313218
[TBL] [Abstract][Full Text] [Related]
12. Identification and comparative analysis of hepatitis C virus-host cell protein interactions.
Dolan PT; Zhang C; Khadka S; Arumugaswami V; Vangeloff AD; Heaton NS; Sahasrabudhe S; Randall G; Sun R; LaCount DJ
Mol Biosyst; 2013 Dec; 9(12):3199-209. PubMed ID: 24136289
[TBL] [Abstract][Full Text] [Related]
13. Target Identification Using Homopharma and Network-Based Methods for Predicting Compounds Against Dengue Virus-Infected Cells.
Hengphasatporn K; Plaimas K; Suratanee A; Wongsriphisant P; Yang JM; Shigeta Y; Chavasiri W; Boonyasuppayakorn S; Rungrotmongkol T
Molecules; 2020 Apr; 25(8):. PubMed ID: 32325755
[TBL] [Abstract][Full Text] [Related]
14. Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference.
Sze A; Olagnier D; Hadj SB; Han X; Tian XH; Xu HT; Yang L; Shi Q; Wang P; Wainberg MA; Wu JH; Lin R
Viruses; 2017 Oct; 9(10):. PubMed ID: 28972551
[TBL] [Abstract][Full Text] [Related]
15. Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents.
Hyrina A; Meng F; McArthur SJ; Eivemark S; Nabi IR; Jean F
PLoS One; 2017; 12(3):e0174483. PubMed ID: 28339489
[TBL] [Abstract][Full Text] [Related]
16. Targeting dengue virus NS4B protein for drug discovery.
Xie X; Zou J; Wang QY; Shi PY
Antiviral Res; 2015 Jun; 118():39-45. PubMed ID: 25796970
[TBL] [Abstract][Full Text] [Related]
17. Dengue Virus Reporter Replicon is a Valuable Tool for Antiviral Drug Discovery and Analysis of Virus Replication Mechanisms.
Kato F; Hishiki T
Viruses; 2016 May; 8(5):. PubMed ID: 27164125
[TBL] [Abstract][Full Text] [Related]
18. Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.
Nakajima S; Watashi K; Ohashi H; Kamisuki S; Izaguirre-Carbonell J; Kwon AT; Suzuki H; Kataoka M; Tsukuda S; Okada M; Moi ML; Takeuchi T; Arita M; Suzuki R; Aizaki H; Kato T; Suzuki T; Hasegawa H; Takasaki T; Sugawara F; Wakita T
J Virol; 2016 Oct; 90(20):9058-74. PubMed ID: 27489280
[TBL] [Abstract][Full Text] [Related]
19. Ten years of dengue drug discovery: progress and prospects.
Lim SP; Wang QY; Noble CG; Chen YL; Dong H; Zou B; Yokokawa F; Nilar S; Smith P; Beer D; Lescar J; Shi PY
Antiviral Res; 2013 Nov; 100(2):500-19. PubMed ID: 24076358
[TBL] [Abstract][Full Text] [Related]
20. Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.
Parkinson T; Pryde DC
Future Med Chem; 2010 Jul; 2(7):1181-203. PubMed ID: 21426163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]